Neupogen and Zopiclone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Neupogen (filgrastim) and Zopiclone (eszopiclone). Common drug interactions include pain in extremity among females and herpes simplex among males.

The phase IV clinical study analyzes what interactions people have when they take Neupogen and Zopiclone. It is created by eHealthMe based on reports of 92 people who take the same drugs from the FDA, and is updated regularly.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

What is Zopiclone?

Zopiclone has active ingredients of eszopiclone. It is often used in insomnia. eHealthMe is studying from 54,331 Zopiclone users. Check the latest studies of Zopiclone.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 28, 2026

92 people who take Neupogen and Zopiclone together, and have interactions are studied.

Neupogen and Zopiclone drug interactions.

What are the common drug interactions of Neupogen and Zopiclone, by gender? *:

female:

  1. Pain in extremity
  2. Palpitations (feelings or sensations that your heart is pounding or racing)
  3. Peripheral swelling
  4. Psoriasis (immune-mediated disease that affects the skin)
  5. Vaginal haemorrhage (vaginal bleeding)
  6. Vomiting
  7. Cellulitis (infection under the skin)
  8. Pneumonia
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Adult t-cell lymphoma/leukaemia (cancer of the immune system's own t-cells)

male:

  1. Herpes simplex (herpes simplex is a common viral infection)
  2. Drug intolerance (drug sensitivity)
  3. Systolic dysfunction (impaired ventricular contraction)
  4. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  5. Anaemia (lack of blood)
  6. Angiosarcoma (cancer of endothelial-type cells that line vessel walls)
  7. Bedridden
  8. Central line infection (infection by central line in icu)
  9. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  10. Colitis (inflammation of colon)

What are the common drug interactions of Neupogen and Zopiclone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Congestive cardiomyopathy (weakening of heart muscle)
  2. Diastolic dysfunction
  3. Dyspnoea exertional (breathlessness or shortness of breath)
  4. Systolic dysfunction (impaired ventricular contraction)
  5. Tachycardia (a heart rate that exceeds the range of 100 beats/min)

20-29:

n/a

30-39:

  1. Cellulitis (infection under the skin)
  2. Hypokalaemia (low potassium)
  3. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  4. Abdominal pain
  5. Atypical pneumonia (acute respiratory disease marked by high fever and coughing)
  6. Colitis (inflammation of colon)
  7. Febrile neutropenia (fever with reduced white blood cells)
  8. Heart rate increased
  9. Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
  10. Respiratory failure (inadequate gas exchange by the respiratory system)

40-49:

  1. Vomiting
  2. Central line infection (infection by central line in icu)
  3. Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Enterococcal infection
  6. Escherichia bacteraemia (presence of bacteria escherichia coli in the blood)
  7. Lymphangitis (inflammation of the lymph channel)
  8. Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
  9. Pyrexia (fever)
  10. Rash scarlatiniform (rash 3-5mm size)

50-59:

  1. Chorioretinitis (an inflammation of the choroid (thin pigmented vascular coat of the eye) and retina of the eye)
  2. Decreased eye contact
  3. Eye allergy
  4. Infection
  5. Influenza like illness
  6. Joint swelling
  7. Oropharyngeal pain
  8. Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
  9. Rash
  10. Rash erythematous (redness of the skin)

60+:

  1. Herpes simplex (herpes simplex is a common viral infection)
  2. Drug intolerance (drug sensitivity)
  3. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  4. Confusional state
  5. Cushingoid (obesity and weakening of the muscles)
  6. Decreased appetite
  7. Diffuse large b-cell lymphoma stage iv (cancer of b cells, a type of white blood cell-stage iv)
  8. Drug ineffective
  9. Epistaxis (bleed from the nose)
  10. Hot flush (sudden feelings of heat)

What are the existing conditions these people have? *

  1. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 30 people, 32.61%
  2. Haemorrhoids (a swollen vein or group of veins in the region of the anus): 26 people, 28.26%
  3. Indigestion: 24 people, 26.09%
  4. Conjunctivitis (pink eye): 23 people, 25.00%
  5. Multiple Myeloma (cancer of the plasma cells): 16 people, 17.39%
  6. White Blood Cell Count Decreased: 10 people, 10.87%
  7. Initial Insomnia (feeling of inadequate or poor-quality sleep): 7 people, 7.61%
  8. Pain: 6 people, 6.52%
  9. High Blood Pressure: 6 people, 6.52%
  10. Cough: 6 people, 6.52%

* Approximation only. Some reports may have incomplete information.

Do you take Neupogen and Zopiclone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Neupogen and Zopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zopiclone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neupogen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zopiclone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on filgrastim and eszopiclone (the active ingredients of Neupogen and Zopiclone, respectively), and Neupogen and Zopiclone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: